We describe a novel strategy to site-specifically mutagenize the genome of an RNA virus by exploiting homologous RNA recombination between synthetic defective interfering (Dl) RNA and the viral RNA. The construction of a full-length cDNA clone, pMIDI, of a Dl RNA of coronavirus MHV strain A59 was reported previously (R.G. Van der Most, P.J. Bredenbeek, and W.J.M. Spaan (1991). J. Virol. 65, 3219-3226). RNA transcribed from this construct, is replicated efficiently In MHV-lnfected cells. Marker mutations introduced In MIDI RNA were replaced by the wild-type residues during replication. More importantly, however, these genetic markers were introduced into the viral genome: even In the absence of positive selection MHV recombinants could be isolated. This finding provides new prospects for the study of coronavirus replication using recombinant DNA techniques. As a first application, we describe the rescue of the temperature sensitive mutant MHV Albany-4 using Dl-dlrected mutagenesis. Possibilities and limitations of this strategy are discussed.
INTRODUCTION
Coronaviruses are a group of enveloped viruses that cause important diseases in domestic animals (for reviews see [1] [2] [3] . The viral genome is a single-stranded, (+)-sense RNA molecule of exceptional length, e.g. the mouse hepatitis virus (MHV) has a genome of 32 kb (4, 5) . Coronaviruses have attracted attention because of their unusual replication strategy, which involves discontinuous RNA synthesis (6, 7) , subgenomic-size replicative forms (8, 9) and homologous RNA recombination (10, 11) .
During mixed infection with different MHV strains, RNA recombination occurs at a remarkably high frequency, both in tissue culture and in infected mice (10) (11) (12) (13) (14) . Moreover, there is evidence for recombination of infectious bronchitis virus genomes in vivo (15) . Although the mechanism is still unknown, homologous RNA recombination in coronavinis-infected cells presumably occurs via template switching ('copy-choice'). As proposed for picornavirus RNA recombination (16, 17) , polymerase complexes containing nascent RNA are thought to dissociate from their original template and anneal to another, after which RNA synthesis proceeds (11) .
We are interested in genetic manipulation of coronaviruses. For several other RNA viruses full-length cDNA clones have been constructed from which infectious RNA can be transcribed in vitro or in vivo (18) (19) (20) (21) (22) (23) (24) . The use of synthetic, infectious RNA allows detailed studies on viral replication and protein function by means of defined genetic changes. Clearly, a full-length cDNA clone would provide the most powerful and elegant tool to study the molecular genetics of coronaviruses. However, the extreme length of the genome poses an obvious technical problem. Here, we describe an alternative strategy to site-specifically introduce mutations into the MHV genome. This strategy exploits the highfrequency RNA recombination that occurs in MHV-infected cells (10, 11) and involves the use of synthetic defective interfering (Dl) RNAs. As delineated by Huang and Baltimore (25, 26) , Dl RNAs are truncated genomes that have retained the replication signals, but depend on proteins encoded by the standard virus for replication and packaging. Dl RNAs are readily generated during high m.o.i. passaging of MHV (27) (28) (29) . Recently, we reported the construction of a full-length cDNA clone of an MHV Dl RNA. RNA, transcribed from this construct in vitro, is efficiently replicated in infected cells (29) . We now provide evidence for homologous RNA recombination between Dl RNA and the standard vims genome. Marker mutations introduced into the synthetic Dl RNA were replaced by the wild-type residues during replication in MHV-infected cells. More importantly however, these marker mutations were found to be incorporated into the genome of MHV-A59. Dl-directed mutagenesis provides exciting new prospects for molecular genetic studies on coronaviruses, as was demonstrated by the rescue of the temperature-sensitive mutant Albany-4.
were grown in Sac~-and 17ClI-cells, respectively. Concentrated virus stocks were prepared by PEG 6000 precipitation of tissue culture supernatants as described (30) . Transfection experiments and undiluted passages of progeny virus were performed in L-cells. Stocks of recombinant vaccinia virus vTF7-3 (obtained from dr. B. Moss; 31) were prepared in rabbit kidney (RK13) cells.
Recombinant DNA techniques
Standard procedures were used for recombinant DNA techniques (32, 33) . DNA sequence analysis was performed using 17 DNA polymerase (Pharmacia) according to the instructions of the manufacturer.
Construction of pMIDI-derivatives
Marker mutations A (G-A; position 1778) and B (T-C; position 2297) were introduced in pMIDI (29) by PCRmutagenesis using oligonucleotide primers VH and VIE (Table  I) and plasmid DNA as template. The generated PCR fragment was cut with Xhol and HincU and used to replace the corresponding Xhol-HincU fragment (nucleotides 1770-2298) in pMEDI. In order to eliminate the UAA termination codon in pMIDI (position 3357), the XhoU-Spel fragment (nucleotides 3237 -3689) of pMIDI was replaced by the corresponding fragment derived from an independent, DI-derived cDNA clone, pDI02 (29) . This fragment contained the wild-type CAA codon at position 3357 and a serendipitous T-C mutation at position 3572 (Marker C), presumably acquired during cDNA synthesis. Sequence analysis of the resulting plasmid pMIDI-C showed that no inadvertent mutations had been acquired during cloning of the DNA fragments and that all fragments were ligated correctly.
A silent T-A substitution, serving as genetic marker, was introduced into the nucleocapsid sequence of pMIDI-C (position 5030) by PCR-mutagenesis using oligonucleotides IX and X (Table I) and pMIDI DNA (29) as template. The 460 bp DNA that was generated by PCR was cut with Accl and Sari and used to replace the corresponding Accl-Sacl (nucleotides 5020-5418) fragment of pMIDI-C. The resulting plasmid was called pMIDI-C*. The presence of the mutation was confirmed by sequence analysis.
Introduction of synthetic DI RNAs into MHV-infected cells
Two procedures were used to introduce DI RNAs into MHVinfected cells. RNA transfection of mouse L-cells using in vitro transcribed RNA and lipofectin (BRL, Life technologies) was performed as described previously (29) . As an alternative, we used DNA transfection and in vivo transcription of plasmid DNA by recombinant vaccinia virus vTF7-3-encoded T7 polymerase (31) . Monolayers of 2 X10 6 L-cells grown in 35 mm wells were infected with vTF7-3 at an multiplicity of infection (m.o.i) of 5 PFU. At 45 min post infection (pi) the inoculum was replaced by DMEM minus FCS, followed by transfection with pMIDI-C* DNA at 90 min pi. For each transfection, 10 /tl lipofectin was diluted in 200 /il DMEM, mixed with 5/ig of pMIDI-C* DNA and kept for 10 min at room temperature. Incubation of vTF7-3 infected cells with this transfection mixture was for 10 min at room temperature, after which 800 /il of DMEM minus FCS was added. Two hours after transfection the cells were super-infected with Albany-4 at an m.o.i. of 10 PFU.
Isolation and analysis of viral RNAs
Intracellular RNA and viral genomic RNA was isolated as described by Spaan et al. (30) . RNA was separated in formaldehyde-agarose gels (32) . The gels were dried and hybridized with 5'-end-labelled oligonucleotide probes as was described by Meinkoth and Wahl (34) . RNA sequence analysis was performed according to Fichot and Girard (35) . Prior to sequencing, the RNA preparations were confirmed to be devoid of MIDI-C and other DI RNAs by hybridization as described above.
cDNA synthesis and PCR amplification
To analyze MTDI-C RNA after replication, intracellular RNA from cells infected with passage 2 virus/DI mixture ( Fig. 2A ) was separated on a non-denaturing, 1 % low melting-point agarose gel. The DI RNA was excised and isolated as described (32) . First strand cDNA synthesis was performed using RNase H-free Moloney Murine Leukemia virus reverse transcriptase (BRL, Life Technologies) followed by PCR-amplification using Taql polymerase (Promega) according to the instructions of the manufacturers. Oligonucleotides I and HI were used. The generated PCR DNA was cut with HindSR (positions 1985 and 3782 in pMIDI-C), the 1.8 kb fragment was cloned into Hindm digested pUC20, followed by CaCl 2 transformation of Escherichia coli strain HB101. To ensure that the resulting bacterial colonies were independent, the cells were recovered for only 30 min at 37°C after heat shocking.
Isolation of MHV recombinants
Passage 2 virus/DI mixture was plaqued as described (30) . Virus from well-isolated plaques was amplified by infecting a monolayer of 2 x 10* L-cells. Intracellular RNA was isolated ACGTGACTCCAGCACACGTC 3'  TGTCAACGAAATTCT 3'  AGACTATAGTCACCCCTATT 3'  TTCCTGAGCCTGTCTACG 3'  TGGCAATCTCGAGCAAAGAGCTATC 3'  AACGAAATTCTTGACAAGCTC 3'  GGGCGTAGACAGGCACAGGAAAAGAAAG 3'  TTTTGTGATTCTTCCAATTGGCCAT 3'  GGGCTTTGCAACGCTTAC 3'  GCTCTTAACTAGTTTGTCCACAAAG 3'   1744  2330  3894  2290  1827  5019  1763  2280  5016  5475  5058  3677 and subjected to cDNA synthesis and PCR amplification using oligonucleotides I and II as described above. The PCR DNA was separated on 1 % agarose-0.5 XTAE gels. Hybridization in dried gels (34) was carried out for 16 hrs at 35°C using 5' end-labelled oligonucleotide IV as a probe in 5XSSPE (0.9 M NaCl, 0.05 M NaPO 4 , pH 7.7, 0.005 M EDTA) containing 5xDenhardt's reagent, 0.05% SDS and 100 /tg/ml alkali-degraded yeast tRNA. The gels were washed 3 x20' at 35°C in 5 xSSPE, 0.05% SDS followed by autoradiography.
RESULTS

Construction of pMIDI-C
We previously reported the construction of pMIDI, a full-length cDNA clone of an MHV DI RNA. pMIDI consists of three noncontiguous regions of the MHV genome, namely the 5' most 3889 nucleotides, the 3' most 806 nucleotides and in between, 799 nucleotides derived from ORFlb of the polymerase gene ( Fig. 1 ). This latter segment contains the encapsidation signal (29, 36) . The three segments are joined in-frame, generating a 'full-length' reading frame for a 184K polypeptide. However, in pMIDI the reading frame is interrupted by a UAA termination codon at position 3357. To study recombination between MHV DI RNAs and the MHV genome, we constructed a pMIDI-derivative, pMIDI-C, in which three silent point mutations were introduced as genetic markers at positions 1778, 2297 and 3572 (mutations A, B and C, respectively; Fig. 1 ). In addition, the termination codon at position 3357 was replaced by the wild-type CAA codon.
Point mutations in MIDI-C are replaced by the wild-type sequence during replication in MHV-A59 infected cells RNA transcribed from pMTDI-C was used for transfection of MHV-infected mouse L-cells. At 12 hrs after transfection the tissue-culture supernatant, containing virus and DI particles, was harvested and passaged twice on fresh L-cells. An outline of the experiment is shown in Fig. 2a . Total intracellular RNA was isolated from passages 0, 1 and 2 (for nomenclature see Fig. 2a ) and analyzed by hybridization using (-) sense oligonucleotide probe VI (Table I) . This probe is complementary to the 3' end of the genome and hybridizes to MIDI-C and all seven MHV RNAs. As shown in Fig. 2b , MIDI-C RNA was replicated in MHV-infected cells and strongly interfered with viral mRNA synthesis in cells infected with passage 1 (pi) virus/DI mixture.
To determine whether recombination had occurred between the MHV genome and the synthetic DI RNA, the sequence of p2 MTDI-C RNA was examined. For this purpose, the DI RNA was subjected to cDNA synthesis followed by PCR amplification (RT-PCR) using the oligonucleotide primers I and III ( Fig. 1 ; Table I ). To prevent in vitro recombination of genomic and DI sequences during RT-PCR, the MIDI-C RNA used as a template was gel-purified. It should be noted that genomic RNA was already present in very low amounts in unfractionated p2 RNA (Fig. 2b) . RT-PCR produced a single, Dl-specific DNA species with an expected length of 1.9 kb. This DNA was digested with Hindm (positions 1985 and 3782 in pMIDI-C) and the resulting 1.8 kb fragment was cloned into pUC20. Sequence analysis of 64 independent clones showed that mutations B and C had been replaced by the wild-type sequence in 14 (22%) and 4 clones (6%) respectively. Mutation A (position 1778) is not located on the cloned //mdlTI fragment and was thus not analyzed.
Since (i) the mutations were exclusively replaced by the wildtype sequence and (ii) the frequency with which the mutations were replaced depended on their distance from the artificial junction of the la and lb segment, reversion by point mutation seems very unlikely. In fact, these results are best explained by homologous RNA recombination between MIDI-C RNA and the genome of the standard virus.
Isolation of MHV recombinants
RNA recombination between MIDI-C RNA and the viral genome could, in principle, also yield recombinant viruses carrying the marker mutations. To study this possibility, p2 virus was plaqued and 150 well-isolated plaques were used to inoculate mouse Lcells. Total cellular RNA, isolated from the infected cells, was subjected to RT-PCR using oligonucleotides I and II ( Fig. 1 ; Table I ). In all cases a DNA fragment with the expected length of 0.6 kb was generated. An additional, faster migrating DNA species was observed consistently and probably represented single-stranded material. Evidently, the 0.6 kb fragment would also be produced with MIDI-C RNA as template ( Fig. 1 ). However, MHV DIs are rapidly lost by infecting at a low m.o.i. (27, 29) and the obtained PCR fragments were therefore expected to be genome-specific.
The PCR-DNAs were screened for the presence of marker mutation B by differential hybridization using the 15-mer POLYMERASE GENE
ORF1a
ORFlb oligonucleotide probe IV (5' TGTCAACGAAATTCT 3', the guanine residue complementary to the introduced cytidine is underlined). PCR-DNA derived from two plaques, 4 and 138, specifically hybridized with this probe (Fig. 3 and not shown) . The RNA preparations that had been used for RT-PCR were confirmed to be devoid of MIDI-C RNA by Northern blot analysis (not shown). Therefore, the hybridization with oligo IV indicated that marker B had been incorporated in the viral genomes.
MIDI-C
To determine whether viruses 4 and 138 were true recombinants, four consecutive plaque purifications were performed. Of each plaque generation, three to five well-isolated plaques were analyzed by differential hybridization of PCRamplified cDNA. Wild-type MHV, treated identically, served as a negative control. In all cases, the progeny of viruses 4 and 138 contained mutation B (not shown), confirming that this genetic marker had been introduced into the viral genome and strongly arguing against MIDI-C contamination.
As a final control, we performed direct RNA sequencing. Stocks of viruses 4 and 138, that had been plaque-purified twice, were used to infect L-cells at an m.o.i. of 10. Intracellular RNAs were harvested and used for RNA sequence analysis using the oligonucleotide primers II and V (Figs. 1, 4 ; Table I ). In the case of virus 4, sequence analysis was also performed on RNA isolated from sucrose-gradient purified virus. In addition to mutation B, the RNAs of viruses 4 and 138 contained mutation A (Fig. 4 ). Analysis of virus 4 RNA using oligonucleotide primer XII (Table I) snowed that mutation C was absent. By using oligonucleotide III as a primer, we could distinguish between MIDI-C RNA and genomic RNA: as shown in Fig. 1 , this oligonucleotide is derived from the 3' end of ORFlb, but in MIDI-C binds immediately downstream of the artificial ORFla/lb junction. Priming on DI RNA would thus yield an ORFla sequence. However, for both intracellular RNA preparations the ORFlb sequence was obtained; consequently, priming by oligonucleotides n, HI, V and XII had occurred on genomic RNA.
On the basis of our combined data, we concluded viruses 4 and 138 to be MHV mutants, generated by homologous RNA recombination between the synthetic MIDI-C RNA and the MHV-A59 genome.
Rescue of the MHV AIbany-4 te-mutant by homologous recombination
Having demonstrated that sequences of synthetic DI RNAs can be introduced into the viral genome via RNA recombination, we explored 'DI-directed mutagenesis' as a means to identify and localize mutations that result in a conditionally lethal phenotype. For this purpose, we used MHV strain Albany-4, a temperaturesensitive (ts-) mutant of MHV-A59. The tt-phenotype of this virus is thought to be the result of an 87 nucleotides deletion in the nucleocapsid (N) gene (nt 1138-1224 of the N-ORF). At 39°C, virus growth is impaired. Also, incubation of Albany-4 virions at 39°C abolishes infectivity (37) . pMIDI-C contains the 3' terminal 510 nucleotides of the wildtype N-ORF including the 87 nucleotides that are deleted in Albany-4 ( Fig. 5 ). Incorporation of the N-sequences of MIDI-C RNA into the Albany-4 genome via RNA recombination should eliminate the ts-defect and generate wild-type MHV. To distinguish rescued Albany-4 recombinants from MHV-A59 contaminants, a silent T-A substitution was introduced into the N sequence of pMIDI-C (nucleotide 1200 of the N-ORF) as a genetic marker (Fig. 5 ). The resulting plasmid was called pMIDI-C*.
In this set of experiments, we used DNA transfection and in vivo transcription by vaccinia virus-expressed T7 polymerase as an alternative to RNA transfection to introduce MIDI-C* into MHV-infected cells. Mouse L-cells, infected with recombinant vaccinia virus vTF7-3 (31), were either transfected with pMTDI-C* DNA or mock-transfected with PBS. Subsequently, these cells were super-infected with MHV Albany-4. After a 25 hi incubation at 33 C C, the tissue culture supernatants were harvested and passaged once at 33°C in fresh L-cells, followed by a single passage at 39°C. Vaccinia virus remains cell-associated, and is therefore lost during passage. The 39°C/p2 virus stocks were used to infect monolayers of L-cells at 37°C. Intracellular RNAs were separated in formaldehyde-agarose gels and hybridized to 5'-end labelled oligonucleotide VI. This probe binds to the (lanes 1 -4) . The RNA preparations were separated in formaldehyde-agarose gels and hybridized to 5'-end labelled oligonucleotide probe VI. sequence, that has been deleted in Albany-4 ( Table 1 ; Fig. 5 ) and is therefore specific for the wild-type N-gene. Strikingly, probe VI not only detected MIDI-C* RNA but also the nested set of MHV mRNAs (Fig. 6 , lanes 'MOCK' and 'MIDI-C*'), indicating that during passage, viruses had accumulated that had incorporated MIDI-C* sequences into their genomes.
PLAQUES
To obtain direct evidence for this, the p2 virus/DI mixture was plaqued at 39 C C and virus from 20 randomly-chosen plaques was propagated in L-cell monolayers. For 19 of these plaque-purified viruses, the intracellular RNAs hybridized to probe VI in a dotblot assay (not shown). Four RNA preparations were analyzed in more detail. Gel-hybridization using oligonucleotide probe VI yielded the nested set of MHV RNAs; MIDI-C* RNA was not detected (Fig. 6, lanes 1 -4) . Sequence analysis showed that the wild-type N-sequence had been restored and that the U-A marker mutation at nucleotide 1200 of the N-ORF was present ( Fig. 7) , providing formal evidence that the isolated viruses were generated by recombination between MIDI-C* RNA and the Albany-4 genomic RNA. 
DISCUSSION
Homologous RNA recombination has been described for a number of positive-stranded RNA viruses (16, 17, 38, 39) . For the coronavims MHV in particular, recombination of genomic RNAs has been well documented (10) (11) (12) (13) 40) . Here, we extend these observations by providing evidence for recombination between DI RNAs and the MHV-A59 genome. The synthetic DI RNA used in this study, MIDI-C, consisted of three non-contiguous parts of the MHV genome: the 5'-most 3889 nucleotides containing the 5' non-translated region and part of ORFla, a 799 nucleotide middle segment derived from ORFlb and 806 nucleotides encompassing the 3' end of the nucleocapsid (N) gene and the 3' non-translated region (29) . We have shown that silent mutations introduced into the ORFla sequence of MIDI-C were exclusively replaced by the wild-type residues during DI replication in MHV-infected cells. These marker mutations, however, were not replaced at an equal rate: markers B and C, located 1500 and 300 nucleotides upstream of the artificial ORFla/lb border in MIDI-C, were replaced in 22% and 6% of the passage 2 DI RNAs, respectively. Apparently, the frequency of replacement correlated with the distance between the mutation and the ORFla/lb border, i.e. the region in which template-switching has to occur in order to remove the mutation while maintaining the original MIDI-C structure. These finding are in accordance with the current model for coronavims RNA recombination, in which template-switching by the viral polymerase occurs randomly (11, 41) . In this model, the probability of recombination in a defined region of an RNA molecule is proportional to the length of this region.
Most convincingly, recombination between MIDI-C RNA and the MHV genomic RNA was demonstrated by the identification of viruses that had incorporated the genetic markers A and B into their genomes. It should be emphasized that these viruses were isolated in the absence of selection. These findings lead to the important conclusion that synthetic DI RNAs can be used to site-specifically alter the MHV genome by exploiting RNA recombination. The potential of Dl-directed mutagenesis is illustrated by the rescue of the conditionally lethal mutant Albany-4. The ty-phenotype of this mutant is caused by a deletion at the 3' end of the N-gene (37) . Viruses that had restored the N-gene by recombination with MIDI-C* RNA, were selected for by passaging the virus/DI mixture at the restrictive temperature.
The fact that synthetic DI RNAs can be used to modify the MHV genome may have important implications. For other RNA viruses, e.g. alphaviruses and picornaviruses, the use of infectious RNA transcripts derived from full-length cDNA clones has profoundly advanced the study of replication and pathogenesis (42) (43) (44) (45) (46) (47) (48) (49) (50) . In the case of MHV however, the construction of a full-length cDNA clone is hampered by the extreme length of the viral genome. Until such a clone becomes available, the only means to generate defined genetic changes will be through homologous RNA recombination. In principle, our mutagenesis strategy, which is reminiscent of that used for large DNA viruses (51, 52) , should be applicable to other coronaviruses as well, provided that these viruses support DI replication and exhibit high frequency RNA recombination. As shown by recent studies, these properties are not unique to MHV (15, 53) .
Several applications of Dl-directed mutagenesis come to mind. Firstly, it should be possible to map other mutations that result in a conditionally lethal phenotype; as for Sindbis vims (42) (43) (44) (45) , the characterization of MHV rs-mutants that exhibit impaired RNA synthesis at the restrictive temperature (54-56), will further our understanding of the coronavirus RNA polymerase. Secondly, it should be possible to introduce mutations that change the biological properties of coronaviruses. In addition to the genes encoding the polymerase and the structural proteins, coronaviruses contain several accessory genes that are not required for growth in tissue culture (57) (58) (59) (60) (61) . By mutating these genes, their role during virus replication in the natural host can be assessed. Finally, foreign sequences, e.g heterologous genes under the control of a transcription-initiation signal, may be introduced at the 3' end of the MHV genome. The isolation of such recombinants will be facilitated by selecting for repair of the Albany-4 te-lesion.
Clearly, there will be limitations in this system: thus far, we have introduced mutations only in the 5' and 3' terminal regions of the MHV genome. It remains to be determined whether mutations can be introduced efficiently into more internal regions, since this would require double recombination events. Also, in the case of mutations causing reduced replication in vitro, the screening for recombinant viruses will be difficult. Presumably, such problems can be solved by improving screening procedures and by applying selection, e.g. via rescue of ty-markers (this paper) or by using neutralizing antibodies (40) . Studies to address these issues are currently in progress.
While this manuscript was being completed, a publication by Koetzner et al. (62) appeared describing the rescue of MHV Albany-4 by targeted RNA recombination using a synthetic mRNA 7 homologue. However, as stated by these authors the observed recombination frequency using this method was too low to allow direct identification of recombinants without selection. In fact, it was anticipated that a more general applicability of targeted RNA recombination would require finding conditions that favour higher rates of recombination of exogenous RNA. The results described in the present paper show that by using synthetic co-replicating DI RNAs site-specific mutations can be introduced efficiently into the MHV genome.
